Ritonavir (RTV, Norvir)
Ritonavir is well absorbed from the gastrointestinal tract and at full doses potently inhibits HIV, but due to poor tolerability it is now used mainly in doses of 100 to 400 mg b.i.d. to enhance the serum concentrations and decrease the dosage frequency of other protease inhibitors.